Skip to main content

Find Clinical Trials

Home
Conditions
Rare Diseases

Clinical trial condition

Rare Diseases

Explore clinical trials studying Rare Diseases. Study availability and eligibility vary by location and protocol.

467 public trials 83 recruiting studies

Refine in advanced search Browse all conditions

Rare Diseases trial results

Completed

Study of the Predictors of the Course and Early Outcome of Patients With Systemic Lupus Erythematosus: Nature Versus Nurture

NCT00006134

Conditions: Arthritis, Autoimmune Diseases, Communicable Diseases, +12 more
Locations: University of Alabama Comprehensive Cancer Center Birmingham, Alabama, United States

University of Texas Medical Branch Galveston, Texas, United States

University of Texas Health Science Center - Houston Houston, Texas, United States

View Trial Details

Completed

Phase II Randomized Study of Leuprolide Vs Oral Contraceptive Therapy Vs Leuprolide and Oral Contraceptive Therapy for Ovarian Hyperandrogenism

NCT00004763

Conditions: 46, XX Disorders of Sex Development, Adrenogenital Syndrome, Congenital Abnormalities, +14 more
Locations: Not specified

View Trial Details

Completed

Diagnostic Pilot Study of Dual Energy Absorptiometry in the Detection of Osteopenia or Osteoporosis in Patients With Thalassemia Major

NCT00006138

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +19 more
Locations: Not specified

View Trial Details

Completed

Phase III Randomized, Double-Blind Study of Prednisone for Duchenne Muscular Dystrophy

NCT00004646

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disease Attributes, Duchenne Muscular Dystrophy, +15 more
Locations: Not specified

View Trial Details

Completed

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Active Systemic Lupus Erythematosus

NCT00004662

Conditions: Arthritis, Autoimmune Diseases, Communicable Diseases, +12 more
Locations: Not specified

View Trial Details

Completed

Phase III Randomized, Double-Blind, Placebo-Controlled Study of 3,4-Diaminopyridine for Demyelinating Polyneuropathy

NCT00004939

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +15 more
Locations: Not specified

View Trial Details

Completed

Phase II Pilot Study of Extracorporeal Phototherapy for Epidermolysis Bullosa Acquisita

NCT00004359

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disease Attributes, +11 more
Locations: Not specified

View Trial Details

Completed

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Copolymer 1 for Relapsing-Remitting Multiple Sclerosis

NCT00004814

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +11 more
Locations: Not specified

View Trial Details

Completed

Randomized Study of Succimer (Dimercaptosuccinic Acid) on Growth of Lead-Poisoned Children

NCT00004838

Conditions: Chemically-Induced Disorders, Disease Attributes, Heavy Metal Poisoning, +5 more
Locations: Not specified

View Trial Details

Completed

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Iloprost for Raynaud's Phenomenon Secondary to Systemic Sclerosis

NCT00004786

Conditions: Arthritis, Cardiovascular Diseases, Connective Tissue Diseases, +18 more
Locations: Not specified

View Trial Details